Antidiarrheals
Key Points
- Antidiarrheal agents reduce intestinal motility and secretion; primary agents activate opioid Mu-receptors in the GI tract.
- Contraindicated when infectious diarrhea is suspected (fever, bloody stool, high-grade pathogens) — slowing motility allows pathogen proliferation.
- Loperamide (Imodium) is first-line OTC antidiarrheal; does not cross the blood-brain barrier at therapeutic doses — minimal CNS effects.
- Diphenoxylate/atropine (Lomotil) is Schedule V; atropine is added to discourage abuse by causing anticholinergic discomfort at high doses.
Pathophysiology
Diarrhea results from increased intestinal motility, reduced fluid/electrolyte absorption, or increased secretion into the intestinal lumen. Causes include viral/bacterial infection, inflammatory bowel disease, irritable bowel syndrome, and chemotherapy-related diarrhea (CRD).
Antidiarrheals work by:
- Binding opioid Mu-receptors in the intestinal wall → inhibit peristalsis → decrease motility → increased water/electrolyte absorption
- Prolonging intestinal transit time → firmer stool
Classification
| Type | Examples | Mechanism |
|---|---|---|
| Opioid-related | Loperamide (Imodium), diphenoxylate/atropine (Lomotil) | Opioid Mu-receptor agonism in GI tract → reduced motility |
| Adjuvant/Adsorbent | Bismuth subsalicylate (Pepto-Bismol), kaolin-pectin | Adsorb toxins; anti-secretory effect |
| Anticholinergic | Hyoscyamine (Levsin) | Reduce GI spasm and secretion |
Nursing Assessment
NCLEX Focus
Before administering an antidiarrheal, assess for signs of infectious diarrhea (fever >101°F, bloody or mucus-containing stool, severe abdominal pain) — antidiarrheals are contraindicated in these cases.
- Assess stool characteristics: frequency, consistency, color (bloody or mucus-containing = infection concern).
- Assess vital signs and hydration status: skin turgor, mucous membranes, daily weights, urine output.
- Assess for fever — withhold antidiarrheal if fever is present and notify provider.
- Assess for diarrhea cause: travel history, recent antibiotics (C. difficile risk), chemotherapy.
- Assess for abdominal pain, bowel sounds, and distention.
Nursing Interventions
- Monitor I&O and daily weights; replace fluids and electrolytes as ordered — diarrhea causes dehydration and electrolyte imbalance.
- Educate patients to avoid caffeine (increases GI motility) during diarrhea episodes.
- Caution patients against driving or operating machinery — drowsiness/dizziness possible with opioid-based agents.
- Do not use diphenoxylate/atropine in patients with liver disease — impaired metabolism increases systemic opioid effects.
Infectious Diarrhea Contraindication
Antidiarrheal drugs should NOT be used when infection is suspected (fever, bloody stool, positive cultures). Slowing motility in infectious diarrhea traps pathogens, worsens illness, and may cause toxic megacolon in C. difficile infection.
Dehydration Assessment
Diarrhea rapidly depletes fluid and electrolytes (sodium, potassium, bicarbonate). Assess for dehydration signs and institute oral rehydration therapy early; IV fluids may be required for severe dehydration.
Pharmacology
| Drug | Schedule | Key Nursing Considerations |
|---|---|---|
| Loperamide (Imodium) | OTC | Does not cross BBB; no CNS effects at therapeutic doses; do not exceed 8 mg/day (OTC limit) |
| Diphenoxylate/atropine (Lomotil) | Schedule V | Atropine added to discourage abuse; anticholinergic side effects at high doses; avoid in liver disease |
| Bismuth subsalicylate (Pepto-Bismol) | OTC | Blackens stool (inform patient); avoid in patients on aspirin or salicylate allergy; avoid in children with viral illness (Reye syndrome risk) |
Clinical Judgment Application
Clinical Scenario
A patient on broad-spectrum antibiotics develops 6 loose stools/day without fever or blood in stool. Loperamide 2 mg after each loose stool is ordered (max 16 mg/day).
- Recognize Cues: Antibiotic-associated diarrhea; absence of fever or bloody stool.
- Analyze Cues: Rule out C. difficile before treating; stool culture may be indicated.
- Prioritize Hypotheses: Fluid/electrolyte replacement first; assess infection status.
- Generate Solutions: Administer per order while monitoring for C. diff symptoms (fever, abdominal cramping, bloody/watery stool).
- Take Action: Administer loperamide; monitor I&O; encourage clear fluids and electrolyte solutions.
- Evaluate Outcomes: Stool frequency decreases; hydration maintained; no signs of C. difficile.
Related Concepts
- diarrhea-assessment-and-management - Comprehensive clinical assessment and nursing management.
- clostridioides-difficile-infection - Major cause of antibiotic-associated diarrhea where antidiarrheals are contraindicated.
- inflammatory-bowel-disease - Chronic disease context where antidiarrheals are used cautiously.
- fluid-volume-deficit-hypovolemia-and-dehydration - Key complication of diarrhea to prevent and treat.
- laxatives - Opposing drug class for constipation management.
Self-Check
- What findings would make antidiarrheals contraindicated in a patient with diarrhea?
- How does loperamide differ from diphenoxylate/atropine in terms of CNS effects?
- Why is bismuth subsalicylate (Pepto-Bismol) avoided in children with viral illnesses?